ISSN: 2332-0877

Jornal de doenças infecciosas e terapia

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Coronavirus Disease 2019: Taxonomy, Genomic Structure, Replication and Pathogenesis

Arunkumar Krishnan, James P Hamilton, Saleh A Alqahtani and Tinsay A Woreta

The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus- 2(SARS-CoV-2). COVID-19 outbreak in Wuhan, China, has now spread too many countries across the world with an increasing death toll. At present, with the rapidly increasing number of cases around the world, which is a significant threat to public health. The World Health Organization has declared the ongoing outbreak as a global public health emergency. Presently, it is vital to control the infection, the transmission route. Due to the absence of adequate evidence, there is still no drug or vaccine that has been officially approved for the treatment. The use of existing drugs to control the progress of the disease and effective option of antiviral treatment, vaccination is currently under development and evaluation. The researchers raced to understand the define the risk factors, the pathogenesis of the disease, develop treatment options, and work on vaccine development. So, it is very vital to understand the structure of the proteins and the genome of the COVID-19. In this review, we summarize current information about the transmissibility, pathogenicity, phenotype features. Furthermore, we discuss the viral characteristics of 2019-nCoV.

Isenção de responsabilidade: Este resumo foi traduzido usando ferramentas de inteligência artificial e ainda não foi revisado ou verificado.